FHC
SUPN icon

First Horizon Corporation’s Supernus Pharmaceuticals SUPN Stock Holding History

First Horizon Corporation’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Sell
458
-671
-59% -$32.2K ﹤0.01% 946
2026
Q1 		$58.4K Sell
1,129
-346
-23% -$17.6K ﹤0.01% 594
2025
Q4 		$73.3K Buy
1,475
+984
+200% +$47.8K ﹤0.01% 582
2025
Q3 		$23.5K Buy
+491
New +$19.8K ﹤0.01% 813

Other funds holding SUPN

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
VIM
VELA Investment Management New Albany, Ohio $468M AUM 18.47% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

First Horizon Corporation's SUPN Position: Q2 2026 in Review

First Horizon Corporation reduced its Supernus Pharmaceuticals (SUPN) stake by 59% in Q2 2026, selling an estimated $32.2K and leaving 458 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #946.

First Horizon Corporation first reported a position in SUPN in Q3 2025 and has held it in 4 quarters since. The position peaked at $73.3K in Q4 2025. 88 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • First Horizon Corporation held 458 shares of Supernus Pharmaceuticals worth $21.3K as of Q2 2026.
  • First Horizon Corporation sold 671 Supernus Pharmaceuticals shares in Q2 2026, an estimated $32.2K.
  • Supernus Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #946 holding.
  • First Horizon Corporation first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Supernus Pharmaceuticals position peaked at $73.3K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.